Human Anti-CLPTM1 Recombinant Antibody (clone 59D04)
Provided herein are monoclonal antibodies capable of binding to the extracellular domain of CLPTM1. The antibody can be used in the treatment or prevention of a condition which is responsive to, or benefits from, (i) immunosuppression, (ii) the reduction or reversal of one or more pro-inflammatory cytokines or the induction of an anti-inflammatory cytokine), (iii) an increase in insulin sensitivity, or (iv) therapy with GDF15 and/or TGF-βand/or IFNβ.
| Supplier | Creative Biolabs |
|---|---|
| Product # | HPAB-N0051-YC |
| Pricing | Inquiry |
| Host | Human |
| Target | CLPTM1 |
| Species Reactivity | Human |
| Type | Human IgG |
| Applications | FuncS |
| Storage | Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |